Brokerages Set Teladoc Health, Inc. (NYSE:TDOC) PT at $17.97

Teladoc Health, Inc. (NYSE:TDOC) has received an average rating of “Hold” from the eighteen research firms that are covering the stock, MarketBeat reports. Twelve investment analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $17.97.

Several analysts have commented on the stock. TD Cowen decreased their price target on shares of Teladoc Health from $16.00 to $15.00 and set a “hold” rating on the stock in a research note on Friday, April 26th. Barclays decreased their price target on shares of Teladoc Health from $25.00 to $20.00 and set an “overweight” rating on the stock in a research note on Friday, April 26th. Evercore ISI decreased their price target on shares of Teladoc Health from $14.00 to $10.00 and set an “in-line” rating on the stock in a research note on Tuesday, July 9th. Wells Fargo & Company reduced their target price on shares of Teladoc Health from $17.00 to $15.00 and set an “equal weight” rating on the stock in a report on Monday, April 29th. Finally, Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a report on Friday, April 26th.

Insiders Place Their Bets

In other news, Director Karen L. Daniel sold 9,834 shares of the company’s stock in a transaction that occurred on Thursday, May 23rd. The shares were sold at an average price of $11.90, for a total value of $117,024.60. Following the completion of the sale, the director now owns 36,995 shares of the company’s stock, valued at approximately $440,240.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, COO Michael Willem Waters sold 5,793 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total value of $73,513.17. Following the completion of the sale, the chief operating officer now owns 64,881 shares of the company’s stock, valued at approximately $823,339.89. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Karen L. Daniel sold 9,834 shares of the stock in a transaction that occurred on Thursday, May 23rd. The shares were sold at an average price of $11.90, for a total transaction of $117,024.60. Following the sale, the director now directly owns 36,995 shares of the company’s stock, valued at approximately $440,240.50. The disclosure for this sale can be found here. Insiders have sold 32,592 shares of company stock worth $397,064 in the last three months. Corporate insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of hedge funds and other institutional investors have recently bought and sold shares of TDOC. ICA Group Wealth Management LLC purchased a new stake in Teladoc Health during the fourth quarter valued at approximately $28,000. Hexagon Capital Partners LLC increased its stake in Teladoc Health by 204.4% during the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 1,065 shares in the last quarter. RIA Advisory Group LLC acquired a new position in Teladoc Health during the 4th quarter valued at approximately $36,000. GAMMA Investing LLC acquired a new position in Teladoc Health during the 4th quarter valued at approximately $41,000. Finally, Principal Securities Inc. acquired a new position in Teladoc Health during the 4th quarter valued at approximately $45,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Down 1.1 %

TDOC opened at $9.29 on Thursday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.74 and a current ratio of 3.82. Teladoc Health has a fifty-two week low of $8.73 and a fifty-two week high of $30.41. The firm’s fifty day moving average is $10.72 and its 200 day moving average is $14.78. The stock has a market cap of $1.58 billion, a price-to-earnings ratio of -6.59 and a beta of 0.94.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The company had revenue of $646.13 million during the quarter, compared to analysts’ expectations of $637.31 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The firm’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.37) EPS. On average, sell-side analysts forecast that Teladoc Health will post -1.05 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.